Teva Pharmaceutical Industries' GAAP loss for 3 months of 2022 was $952 million, against a profit of $84 million in the previous year. Revenues decreased by 8.1% to $3.661 billion from $3.982 billion the year before.
Teva Pharmaceutical Industries' GAAP loss for 3 months of 2022 was $952 million, against a profit of $84 million in the previous year. Revenues decreased by 8.1% to $3.661 billion from $3.982 billion the year before. 
ir.tevapharm.com
English (US) 